NO20054765L - Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav - Google Patents

Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav

Info

Publication number
NO20054765L
NO20054765L NO20054765A NO20054765A NO20054765L NO 20054765 L NO20054765 L NO 20054765L NO 20054765 A NO20054765 A NO 20054765A NO 20054765 A NO20054765 A NO 20054765A NO 20054765 L NO20054765 L NO 20054765L
Authority
NO
Norway
Prior art keywords
effective amount
probiotic organism
preparation
methods
consists essentially
Prior art date
Application number
NO20054765A
Other languages
English (en)
Other versions
NO20054765D0 (no
Inventor
Mitchell Skop
Dilip Chokshi
Original Assignee
Pharmachem Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachem Lab Inc filed Critical Pharmachem Lab Inc
Publication of NO20054765D0 publication Critical patent/NO20054765D0/no
Publication of NO20054765L publication Critical patent/NO20054765L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G3/366—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

2005-12-19 S a m m e n d r a g Det beskrives en myk, tyggbar tilberedning oppnådd uten bruk av sterk varme eller dehydratisering. I én utførelsesform inneholder tilberedningen et virkestoff som i det vesentlige består av en effektiv mengde av minst én probiotisk organisme. I en annen utførelsesform består tilberedningen i det vesentlige av en effektiv mengde av minst én probiotisk organisme og en effektiv mengde av minst ett prebiotisk middel. I en ytterligere utførelsesform består tilberedningen i det vesentlige av en effektiv mengde av minst én probiotisk organisme og et næringsstoff som inngår i en glykoproteinmatriks, eller et enzym, eller begge deler. I nok en annen utførelsesform består tilberedningen i det vesentlige av minst én probiotisk organisme, minst ett prebiotisk middel, og et næringsstoff som inngår i en glykoproteinmatriks, eller et enzym, eller begge deler.
NO20054765A 2003-04-02 2005-10-17 Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav NO20054765L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45978903P 2003-04-02 2003-04-02
PCT/US2004/010164 WO2004089290A2 (en) 2003-04-02 2004-04-01 Novel probiotic compositions and methods of using the same

Publications (2)

Publication Number Publication Date
NO20054765D0 NO20054765D0 (no) 2005-10-17
NO20054765L true NO20054765L (no) 2005-12-19

Family

ID=33159691

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054765A NO20054765L (no) 2003-04-02 2005-10-17 Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav

Country Status (6)

Country Link
US (1) US20060263344A1 (no)
EP (1) EP1608314A2 (no)
AU (1) AU2004227998A1 (no)
CA (1) CA2519927A1 (no)
NO (1) NO20054765L (no)
WO (1) WO2004089290A2 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2476619C (en) * 2002-02-21 2011-09-20 Societe Des Produits Nestle S.A. Pet food composition for skin photoprotection
RU2377980C2 (ru) * 2005-08-17 2010-01-10 Хилл`С Пет Ньютришн, Инк. Способы и композиции для профилактики и лечения заболеваний почек
AU2007292426A1 (en) * 2006-09-05 2008-03-13 Mcneil Nutritionals, Llc Lactase-containing comestibles and related methods
AU2008246387B2 (en) 2007-05-03 2014-06-12 Tobias Olofsson Novel bacteria isolated from fresh honey or the honey producing tract of honey bees
GB0709162D0 (en) * 2007-05-11 2007-06-20 Jagotec Ag Dosage foam
EP2187756A1 (en) * 2007-08-24 2010-05-26 Barry Callebaut AG Process and confectionery product produced thereby
RU2010132283A (ru) * 2008-02-06 2012-03-20 Дзе Проктер Энд Гэмбл Компани (US) Композиции, способы и наборы для повышения иммунного ответа на респираторное заболевание
CA2750192C (en) * 2008-12-30 2016-11-08 Hill's Pet Nutrition, Inc. Methods for increasing the palatability of companion animal food compositions
DK2367549T3 (da) 2008-12-30 2013-11-04 Hills Pet Nutrition Inc Anvendelse af alfalipoinsyre til behandling eller forebyggelse af nedbrydende ledsygdomme, osteoarthritis, bruskskade, og relaterede lidelser hos kæledyr
MX2012002039A (es) * 2009-08-18 2012-04-11 Nestec Sa Una composicion nutricional que comprende cepas de lactococcus y que reduce los sintomas de la alergia, especialmente en infantes y en niños.
US20110123677A1 (en) * 2009-11-25 2011-05-26 Pepsico, Inc. High acid beverage products and methods to extend probiotic stability
DE102010009582A1 (de) * 2010-02-05 2011-08-11 Vitacare GmbH & Co. KG, 60318 Mittel zur Anwendung bei Lactasemangel und Lactoseintoleranz
KR101659062B1 (ko) * 2010-02-08 2016-09-21 영남대학교 산학협력단 미국부저병의 원인균에 대한 항균활성을 가지는 페디오코커스 파버러스 ｙｍｌ ００２, 상기 미생물을 함유하는 항균성 미생물제제 및 상기 미생물을 이용한 방제방법
KR101658377B1 (ko) * 2010-02-08 2016-09-21 영남대학교 산학협력단 미국부저병의 원인균에 대한 항균활성을 가지는 락토바실러스 플란타룸 ｙｍｌ ００１, 상기 미생물을 함유하는 항균성 미생물제제 및 상기 미생물을 이용한 방제방법
US20120015075A1 (en) * 2010-07-13 2012-01-19 Hero Nutritionals, LLC Chewable supplement with live microorganisms
CN111518866A (zh) 2011-03-01 2020-08-11 群体创新有限责任公司 用于治疗与致病生物膜相关之病症的材料和方法
RU2460776C9 (ru) * 2011-04-21 2012-11-10 Общество с ограниченной ответственностью "Бифилюкс" Штамм lactobacillus acidophilus, используемый для получения продукции, содержащей лактобактерии
WO2012173587A1 (en) * 2011-06-13 2012-12-20 Hero Nutritionals, LLC Sugar-free chewable supplement
CN106890317A (zh) * 2015-12-17 2017-06-27 吴波峰 一种乳糖酶组合物及其应用
US20190269740A1 (en) * 2016-10-26 2019-09-05 Nutech Ventures Use of probiotic bacterial strains and cell extracts to inhibit acidosis and liver abscesses in cattle
EA202090769A1 (ru) * 2018-05-04 2020-06-11 Борис Славинович ФАРБЕР Пищевая, косметическая и фармацевтическая композиция с иммуномодулирующим и протективным антивирусным эффектом
CN109793091A (zh) * 2019-04-03 2019-05-24 江苏惠田农业科技开发有限公司 一种复合莓软糖及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000502087A (ja) * 1995-12-15 2000-02-22 ナショナル リサーチ カウンシル オブ カナダ アジュバンドおよび送達賦形剤としての、アーケオソーム類、補酵素ｑ▲下１０▼を含有するアーケオソーム類、および補酵素ｑ▲下１０▼を含有する他の種類のリポソーム類
US6517886B1 (en) * 1997-06-24 2003-02-11 Biovail Corporation International Positive hydration method of preparing confectionery and the resulting product
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
CN1330253C (zh) * 2000-06-13 2007-08-08 荷兰联合利华有限公司 含有无活力乳酸杆菌的食物制品
US6558718B1 (en) * 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation

Also Published As

Publication number Publication date
NO20054765D0 (no) 2005-10-17
EP1608314A2 (en) 2005-12-28
WO2004089290A2 (en) 2004-10-21
CA2519927A1 (en) 2004-10-21
AU2004227998A1 (en) 2004-10-21
WO2004089290A3 (en) 2006-09-08
US20060263344A1 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
NO20083940L (no) Fremgangsmater for redusering av proteinaggregering
WO2004089290A3 (en) Novel probiotic compositions and methods of using the same
BRPI0514293A (pt) sais de dicetopiperazina, sais de dicetomorfolina ou sais de dicetodioxano para administração de droga
DK1423023T3 (da) Sammensætning med bakteriostatisk og baktericid aktivitet mod bakterielle sporer og vegetative celler samt fremgangsmåde til behandling af födevarer dermed
ATE453397T1 (de) Probiotische tablettenformulierungen
EP1411118A4 (en) Cell proliferation inhibitors with anti-glycanic-3 antibody
BR0209057A (pt) Composições herbicidas contendo benzoilciclohexanodionas e protetores
BR112017011067A2 (pt) cepas e métodos para a partição de energia em ruminantes
IL211085A0 (en) Perfusion solution
MXPA05012319A (es) Suministro de compuestos con celulas sanguineas rehidratadas.
AR038207A1 (es) Composicion farmaceutica dispersable oralmente de agomelatina
EP2275121A3 (en) Protein-based streptococcus pneumoniae vaccines
WO2005065456A3 (de) Wirkstoffkombinationen mit insektiziden eigenschaften
BRPI0821373B8 (pt) composições farmacêuticas contendo ao menos um princípio ativo protéico protegido de enzimas digestivas
NO20060955L (no) Farmasoytisk sammensetning som er nyttig til stamcellemobilisering
WO2005004795A3 (en) Compositions and methods for targeted drug delivery
BR0111584A (pt) Método para a produção de um produto alimentìcio comprendendo bactérias de lactobacilos não viáveis, e, produto alimentìcio
BR0314402A (pt) Expansão ex-vivo de populações de células raìzes em culturas celulares mononucleares
DE60107718D1 (de) Konservierung von zellen
GB2443793B (en) Product, method of manufacture and use
BR0112514A (pt) Usos para inibidores de nad sintetase
FR2883184B1 (fr) Composition de spirulines riche en principes actifs, procede d'obtention et utilisation
UA101140C2 (ru) Комбинация рекомбинантной микобактерии и биологически активного агента как вакцины
Sultan et al. Effect of Saccharomyces cerevisiae supplemented with silver nanoparticles on Propionibacterium acnes in vitro
ITFI20060255A1 (it) Composizione agrochimica, e metodo di trattamento di vegetali conmprendente la somministrazione di tale composizione

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application